APA (7th ed.) Citation

Sun, J., Hu, Y., Guo, H., Jing, X., Xu, Z., Sun, F., . . . Xu, J. (2019). Diltiazem used as a tacrolimus-sparing agent for treatment of pediatric patients with refractory nephrotic syndrome: A case report and retrospective analysis. European journal of clinical pharmacology, 75(4), 591-593. https://doi.org/10.1007/s00228-018-2604-4

Chicago Style (17th ed.) Citation

Sun, Jie-Yu, et al. "Diltiazem Used as a Tacrolimus-sparing Agent for Treatment of Pediatric Patients with Refractory Nephrotic Syndrome: A Case Report and Retrospective Analysis." European Journal of Clinical Pharmacology 75, no. 4 (2019): 591-593. https://doi.org/10.1007/s00228-018-2604-4.

MLA (9th ed.) Citation

Sun, Jie-Yu, et al. "Diltiazem Used as a Tacrolimus-sparing Agent for Treatment of Pediatric Patients with Refractory Nephrotic Syndrome: A Case Report and Retrospective Analysis." European Journal of Clinical Pharmacology, vol. 75, no. 4, 2019, pp. 591-593, https://doi.org/10.1007/s00228-018-2604-4.